CEFUROXIME Side Effects

6565968-6 | Clostridium Difficile Colitis, Dehydration, Pneumonia
on Jan 29, 2010 Male patient from UNITED STATES , 83 years of age, weighting 207.2 lb, was treated with Cefuroxime (View Usage). Patient experienced the following unwanted or unexpected effects: clostridium difficile colitis, dehydration, pneumonia (What is pneumonia?). Cefuroxime dosage: 500 Mg Bid Po. During the same period patient was treated with AZITHROMYCIN (250 Mg Every Day Po) (View Azithromycin Review and Azithromycin Label ). Patient was hospitalized.

6554427-2 | Jaundice
Patient was taking Cefuroxime (View Usage). Patient had the following side effects: jaundice (What is jaundice?) on Jan 19, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 66 years of age, was diagnosed with campylobacter infection and. Cefuroxime dosage: 1.5 Mg, Tid. During the same period patient was treated with AMOXICILLIN AND CLAVULANATE POTASSIUM (625 Mg, Unk) (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), METRONIDAZOLE (500 Mg, Tid) (View Metronidazole Review and Metronidazole Label ), BENDROFLUMETHIAZIDE (2.5 Mg, Qd) (View Bendroflumethiazide Review and Bendroflumethiazide Label ), LOPERAMIDE (2 Mg, As Necessary) (View Loperamide Review and Loperamide Label ), MEBEVERINE (135 Mg, Tid) (View Mebeverine Review and Mebeverine Label ), PROCHLORPERAZINE (5 Unk, Tid) (View Prochlorperazine Review and Prochlorperazine Label ). Patient was hospitalized.

6532450-1 | Abdominal Pain Lower, Amenorrhoea, Device Dislocation, Nausea, Staphylococcal Sepsis, Suprapubic Pain, Urinary Tract Infection
Adverse event was reported on Dec 31, 2009 by a Female patient taking Cefuroxime (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?), contraception and. Location: UNITED KINGDOM , 34 years of age, After Cefuroxime was administered, patient had the following side effects: abdominal pain lower, amenorrhoea, device dislocation, nausea (What is nausea?), staphylococcal sepsis, suprapubic pain, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), LEVONORGESTREL (20 Ug, Unk) (View Levonorgestrel Review and Levonorgestrel Label ). Patient was hospitalized.

6527546-4 | Angioedema, Eye Swelling, Skin Oedema, Urticaria
on Jan 04, 2010 Female patient from UNITED STATES , 51 years of age, weighting 153.0 lb, was diagnosed with otitis externa and was treated with Cefuroxime (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema, eye swelling, skin oedema, urticaria. Cefuroxime dosage: 500 Mg Bid Po.


6474732-8 | Retinal Injury, Visual Acuity Reduced
on Nov 25, 2009 Female patient from UNITED KINGDOM , 80 years of age, was diagnosed with cataract operation, mydriasis, cycloplegia and was treated with Cefuroxime (View Usage). Patient had the following side effects: retinal injury, visual acuity reduced. Cefuroxime dosage: . During the same period patient was treated with ADRENALINE (View Adrenaline Review and Adrenaline Label ), SODIUM HYALURONATE (View Sodium Hyaluronate Review and Sodium Hyaluronate Label ), BALANCED SALT (View Balanced Salt Review and Balanced Salt Label ), PHENYLEPHRINE (View Phenylephrine Review and Phenylephrine Label ), CYCLOPENTOLATE HCL (View Cyclopentolate Hcl Review and Cyclopentolate Hcl Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), POVIDONE IODINE (View Povidone Iodine Review and Povidone Iodine Label ), MAXITROL SOLN (View Maxitrol Soln Review and Maxitrol Soln Label ).

6457153-3 | Abdominal Pain, Diarrhoea, Nausea, Pseudomembranous Colitis, Pyrexia
Patient was taking Cefuroxime (View Usage). After Cefuroxime was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea, nausea (What is nausea?), pseudomembranous colitis, pyrexia on Nov 23, 2009 from GERMANY Additional patient health information: Female patient , 26 years of age, weighting 116.8 lb, was diagnosed with inflammatory bowel disease, lymphadenitis and. Cefuroxime dosage: 1.5g Twice Per Day. During the same period patient was treated with CEFUROXIM AXETIL (250mg Twice Per Day) (View Cefuroxim Axetil Review and Cefuroxim Axetil Label ), CIPRO (400mg Twice Per Day) (View Cipro Review and Cipro Label ), CLINDA SAAR (600mg Twice Per Day) (View Clinda-saar Review and Clinda-saar Label ), GENTAMICIN (160mg Single Dose) (View Gentamicin Review and Gentamicin Label ), HYLAK (2ml Three Times Per Day) (View Hylak Review and Hylak Label ), METRONIDAZOL IV (500mg Twice Per Day) (View Metronidazol Iv Review and Metronidazol Iv Label ). Patient was hospitalized.

6451011-6 | Corneal Abrasion, Retinogram Abnormal
Adverse event was reported on Nov 10, 2009 by a Female patient taking Cefuroxime (View Usage) (Dosage: ) was diagnosed with cataract operation, mydriasis, cycloplegia and. Location: UNITED KINGDOM , 59 years of age, Patient experienced the following unwanted or unexpected effects: corneal abrasion, retinogram abnormal. During the same period patient was treated with PHENYLEPHRINE (View Phenylephrine Review and Phenylephrine Label ), CYCLOPENTOLATE HCL (View Cyclopentolate Hcl Review and Cyclopentolate Hcl Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), SODIUM HYALURONATE (View Sodium Hyaluronate Review and Sodium Hyaluronate Label ), ADRENALINE (View Adrenaline Review and Adrenaline Label ), WATER FOR INJECTIONS (View Water For Injections Review and Water For Injections Label ), POVIDONE IODINE (View Povidone Iodine Review and Povidone Iodine Label ), MAXITROL (DROPS) (View Maxitrol (drops) Review and Maxitrol (drops) Label ).

6428117-0 | Diplopia, Metamorphopsia, Renal Impairment
on Oct 22, 2009 Female patient from UNITED KINGDOM , 59 years of age, weighting 183.0 lb, was diagnosed with infection (What is infection?) and was treated with Cefuroxime (View Usage). Patient had the following side effects: diplopia, metamorphopsia, renal impairment. Cefuroxime dosage: 7.5 Mg, Intravenous. During the same period patient was treated with TEICOPLANIN (TEICOPLANIN) (200 Mg, Intravenous) (View Teicoplanin (teicoplanin) Review and Teicoplanin (teicoplanin) Label ), AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), GLICLAZIDE (GLICLAZIDE) (View Gliclazide (gliclazide) Review and Gliclazide (gliclazide) Label ), LYRICA (View Lyrica Review and Lyrica Label ), MORPHINE SULFATE INJ (View Morphine Sulfate Inj Review and Morphine Sulfate Inj Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PIOGLITAZONE HCL (View Pioglitazone Hcl Review and Pioglitazone Hcl Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6419709-3 | Abdominal Pain, Diarrhoea, Nausea, Pseudomembranous Colitis, Pyrexia
on Oct 19, 2009 Female patient from GERMANY , 26 years of age, weighting 116.8 lb, was diagnosed with inflammatory bowel disease, lymphadenitis and was treated with Cefuroxime (View Usage). After Cefuroxime was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea, nausea (What is nausea?), pseudomembranous colitis, pyrexia. Cefuroxime dosage: 1.5g Twice Per Day. During the same period patient was treated with CEFUROXIM AXETIL (250mg Twice Per Day) (View Cefuroxim Axetil Review and Cefuroxim Axetil Label ), CIPRO (400mg Twice Per Day) (View Cipro Review and Cipro Label ), CLINDA SAAR (600mg Twice Per Day) (View Clinda-saar Review and Clinda-saar Label ), GENTAMICIN (160mg Single Dose) (View Gentamicin Review and Gentamicin Label ), HYLAK (2ml Three Times Per Day) (View Hylak Review and Hylak Label ), METRONIDAZOL IV (500mg Twice Per Day) (View Metronidazol Iv Review and Metronidazol Iv Label ). Patient was hospitalized.

6415966-8 | Diplopia, Metamorphopsia, Renal Impairment
Patient was taking Cefuroxime (View Usage). Patient experienced the following unwanted or unexpected effects: diplopia, metamorphopsia, renal impairment on Oct 22, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 59 years of age, weighting 183.0 lb, was diagnosed with infection (What is infection?), back pain (What is back pain?), dyspepsia, cardiovascular event prophylaxis and. Cefuroxime dosage: . During the same period patient was treated with TEICOPLANIN (View Teicoplanin Review and Teicoplanin Label ), LYRICA (View Lyrica Review and Lyrica Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), MS CONTIN (View Ms Contin Review and Ms Contin Label ), AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6407478-2 | Ageusia
Adverse event was reported on Oct 05, 2009 by a Male patient taking Cefuroxime (View Usage) (Dosage: Intravenous`) was diagnosed with fibula fracture, open fracture and. Location: UNITED KINGDOM , 73 years of age, weighting 207.2 lb, Patient had the following side effects: ageusia. During the same period patient was treated with QVAR (View Qvar Review and Qvar Label ), SALBUTAMOL (SALBUTAMOL) (View Salbutamol (salbutamol) Review and Salbutamol (salbutamol) Label ).

6407334-X | Convulsion, Fall, Loss Of Consciousness, Salivary Hypersecretion
on Oct 12, 2009 Female patient from GERMANY , child 7 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Cefuroxime (View Usage). After Cefuroxime was administered, patient had the following side effects: convulsion, fall (What is fall?), loss of consciousness, salivary hypersecretion. Cefuroxime dosage: 10ml Twice Per Day. Patient was hospitalized.

6399218-0 | Epilepsy
on Sep 29, 2009 Male patient from UNITED KINGDOM , 75 years of age, was diagnosed with pneumonia (What is pneumonia?), epilepsy (What is epilepsy?) and was treated with Cefuroxime (View Usage). Patient experienced the following unwanted or unexpected effects: epilepsy (What is epilepsy?). Cefuroxime dosage: 2 Courses. During the same period patient was treated with VALPROATE SODIUM (500 Mg, Bid) (View Valproate Sodium Review and Valproate Sodium Label ), ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), ALENDRONIC ACID (ALENDRONIC ACID) (View Alendronic Acid (alendronic Acid) Review and Alendronic Acid (alendronic Acid) Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), CRESTOR (View Crestor Review and Crestor Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), RANITI9DINE (RANITIDINE) (View Raniti9dine (ranitidine) Review and Raniti9dine (ranitidine) Label ).

6397149-3 | Epilepsy
Patient was taking Cefuroxime (View Usage). Patient had the following side effects: epilepsy (What is epilepsy?) on Oct 08, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 75 years of age, was diagnosed with pneumonia (What is pneumonia?), epilepsy (What is epilepsy?) and. Cefuroxime dosage: . During the same period patient was treated with EPILIM (500mg Twice Per Day) (View Epilim Review and Epilim Label ), ADALAT (View Adalat Review and Adalat Label ), ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ), CARDICOR (View Cardicor Review and Cardicor Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), CRESTOR (View Crestor Review and Crestor Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ).

6397148-1 | Convulsion
Adverse event was reported on Oct 08, 2009 by a Male patient taking Cefuroxime (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?), epilepsy (What is epilepsy?) and. Location: UNITED KINGDOM , 75 years of age, After Cefuroxime was administered, patient had the following side effects: convulsion. During the same period patient was treated with EPILIM (1000mg Per Day) (View Epilim Review and Epilim Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ADALAT (View Adalat Review and Adalat Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), CARDICOR (View Cardicor Review and Cardicor Label ), CRESTOR (View Crestor Review and Crestor Label ), ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ).

6393544-7 | Ageusia
on Oct 02, 2009 Male patient from UNITED KINGDOM , 73 years of age, weighting 207.2 lb, was diagnosed with asthma (What is asthma?) and was treated with Cefuroxime (View Usage). Patient experienced the following unwanted or unexpected effects: ageusia. Cefuroxime dosage: . During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), QVAR 40 (View Qvar 40 Review and Qvar 40 Label ).

6390758-7 | Epilepsy
on Sep 29, 2009 Male patient from UNITED KINGDOM , 75 years of age, was diagnosed with pneumonia (What is pneumonia?), epilepsy (What is epilepsy?) and was treated with Cefuroxime (View Usage). Patient had the following side effects: epilepsy (What is epilepsy?). Cefuroxime dosage: . During the same period patient was treated with VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ).

6389331-6 | Pharyngeal Oedema, Swelling Face
Patient was taking Cefuroxime (View Usage). After Cefuroxime was administered, patient had the following side effects: pharyngeal oedema, swelling face on Sep 25, 2009 from UNITED KINGDOM Additional patient health information: Male patient , child 9 years of age, weighting 67.46 lb, was diagnosed with appendicitis (What is appendicitis?), seasonal allergy and. Cefuroxime dosage: 250 Mg, Unk. During the same period patient was treated with METRONIDAZOLE (200 Mg, Unk) (View Metronidazole Review and Metronidazole Label ), IBRUPROFEN (150 Mg, Unk) (View Ibruprofen Review and Ibruprofen Label ), PARACETAMOL (450 Mg, Unk) (View Paracetamol Review and Paracetamol Label ), PIRITON (View Piriton Review and Piriton Label ).

6386817-5 | Epilepsy
Adverse event was reported on Sep 29, 2009 by a Male patient taking Cefuroxime (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?), epilepsy (What is epilepsy?) and. Location: UNITED KINGDOM , 75 years of age, Patient experienced the following unwanted or unexpected effects: epilepsy (What is epilepsy?). During the same period patient was treated with EPILIM (500mg Twice Per Day) (View Epilim Review and Epilim Label ), ADALAT (View Adalat Review and Adalat Label ), ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ), CARDICOR (View Cardicor Review and Cardicor Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), CRESTOR (View Crestor Review and Crestor Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ).

6386814-X | Convulsion
on Sep 29, 2009 Male patient from UNITED KINGDOM , 75 years of age, was diagnosed with pneumonia (What is pneumonia?), epilepsy (What is epilepsy?) and was treated with Cefuroxime (View Usage). Patient had the following side effects: convulsion. Cefuroxime dosage: . During the same period patient was treated with EPILIM (1000mg Per Day) (View Epilim Review and Epilim Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ADALAT (View Adalat Review and Adalat Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), CARDICOR (View Cardicor Review and Cardicor Label ), CRESTOR (View Crestor Review and Crestor Label ), ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ).

6382607-8 | Convulsion, Fall, Loss Of Consciousness, Salivary Hypersecretion
on Sep 25, 2009 Female patient from GERMANY , child 7 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Cefuroxime (View Usage). After Cefuroxime was administered, patient had the following side effects: convulsion, fall (What is fall?), loss of consciousness, salivary hypersecretion. Cefuroxime dosage: 10ml Twice Per Day. Patient was hospitalized.

6379471-X | Pharyngeal Oedema, Swelling Face
Patient was taking Cefuroxime (View Usage). Patient experienced the following unwanted or unexpected effects: pharyngeal oedema, swelling face on Sep 21, 2009 from UNITED KINGDOM Additional patient health information: Male patient , child 9 years of age, weighting 67.46 lb, was diagnosed with appendicitis (What is appendicitis?), pain (What is pain?) and. Cefuroxime dosage: . During the same period patient was treated with METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), PIRITON (View Piriton Review and Piriton Label ).

6376839-2 | Pemphigus
Adverse event was reported on Sep 11, 2009 by a Male patient taking Cefuroxime (View Usage) (Dosage: Oral) was diagnosed with pharyngitis bacterial and. Location: ITALY , 14 years of age, Patient had the following side effects: pemphigus (What is pemphigus?).

6337145-5 | Clostridium Difficile Colitis
on Aug 20, 2009 Female patient from UNITED KINGDOM , 86 years of age, was diagnosed with pneumonia aspiration and was treated with Cefuroxime (View Usage). After Cefuroxime was administered, patient had the following side effects: clostridium difficile colitis. Cefuroxime dosage: 750 Mg, Tid, Intravenous. During the same period patient was treated with METRONIDAZOLE (500 Mg, Tid, Intravenous) (View Metronidazole Review and Metronidazole Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CALCICHEW D3 (CALCIUM CARBONATE, COLECALCIFEROL) (View Calcichew D3 (calcium Carbonate, Colecalciferol) Review and Calcichew D3 (calcium Carbonate, Colecalciferol) Label ), CALCIUM (CALCIUM) (View Calcium (calcium) Review and Calcium (calcium) Label ), CETIRIZINE (View Cetirizine Review and Cetirizine Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), MADOPAR (BENSERAZIDE HYDROCHLORIDE, LEVODOPA) (View Madopar (benserazide Hydrochloride, Levodopa) Review and Madopar (benserazide Hydrochloride, Levodopa) Label ).

6329448-5 | Clostridial Infection, Clostridium Difficile Colitis
on Aug 20, 2009 Female patient from UNITED KINGDOM , 86 years of age, was treated with Cefuroxime (View Usage). Patient experienced the following unwanted or unexpected effects: clostridial infection, clostridium difficile colitis. Cefuroxime dosage: 2250mg Per Day. During the same period patient was treated with METRONIDAZOLE (1500mg Per Day) (View Metronidazole Review and Metronidazole Label ), CALCICHEW D3 (View Calcichew D3 Review and Calcichew D3 Label ), CETIRIZINE HCL (10mg Per Day) (View Cetirizine Hcl Review and Cetirizine Hcl Label ), FLUCONAZOLE (50mg Per Day) (View Fluconazole Review and Fluconazole Label ), LANSOPRAZOLE (30mg Per Day) (View Lansoprazole Review and Lansoprazole Label ), MADOPAR (375mg Per Day) (View Madopar Review and Madopar Label ), NYSTATIN (4ml Per Day) (View Nystatin Review and Nystatin Label ), PARACETAMOL (4g Per Day) (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6317287-0 | Flushing, Infusion Site Inflammation, Infusion Site Pain, Rash, Tachycardia, Tachypnoea
Patient was taking Cefuroxime (View Usage). Patient had the following side effects: flushing, infusion site inflammation, infusion site pain, rash (What is rash?), tachycardia, tachypnoea on Aug 10, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 16 years of age, was diagnosed with postoperative care and. Cefuroxime dosage: 750 Mg, Unk. During the same period patient was treated with METRONIDAZOLE (500 Mg, Unk) (View Metronidazole Review and Metronidazole Label ).

6313619-8 | Exposure To Toxic Agent, Maculopathy, Retinogram Abnormal, Visual Acuity Reduced
Adverse event was reported on Aug 05, 2009 by a Male patient taking Cefuroxime (View Usage) (Dosage: 250 Mg) was diagnosed with cataract operation and. Location: UNITED KINGDOM , 79 years of age, After Cefuroxime was administered, patient had the following side effects: exposure to toxic agent, maculopathy, retinogram abnormal, visual acuity reduced. During the same period patient was treated with EPINEPHRINE (View Epinephrine Review and Epinephrine Label ), PHENYLEPHRINE (PHENYLEPHRINE) 10% (View Phenylephrine (phenylephrine) 10% Review and Phenylephrine (phenylephrine) 10% Label ), SODIUM HYALURONATE (HYALURONATE SODIUM) (View Sodium Hyaluronate (hyaluronate Sodium) Review and Sodium Hyaluronate (hyaluronate Sodium) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), CYCLOPENTOLATE (CYCLOPENTOLATE) (View Cyclopentolate (cyclopentolate) Review and Cyclopentolate (cyclopentolate) Label ), ACETAZOLAMIDE (View Acetazolamide Review and Acetazolamide Label ), GLICLAZIDE (GLICLAZIDE) (View Gliclazide (gliclazide) Review and Gliclazide (gliclazide) Label ).

6309273-1 | Flushing, Infusion Site Inflammation, Infusion Site Pain, Rash, Tachycardia, Tachypnoea
on Jul 31, 2009 Male patient from , 16 years of age, was diagnosed with postoperative care and was treated with Cefuroxime (View Usage). Patient experienced the following unwanted or unexpected effects: flushing, infusion site inflammation, infusion site pain, rash (What is rash?), tachycardia, tachypnoea. Cefuroxime dosage: 750mg, Iv. During the same period patient was treated with METRONIDAZOLE (500mg, Iv) (View Metronidazole Review and Metronidazole Label ).

6308074-8 | Clostridium Difficile Colitis
on Aug 04, 2009 Female patient from GERMANY , 21 years of age, weighting 129.4 lb, was diagnosed with respiratory tract infection and was treated with Cefuroxime (View Usage). Patient had the following side effects: clostridium difficile colitis. Cefuroxime dosage: 500mg Twice Per Day. During the same period patient was treated with DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ). Patient was hospitalized.

6306641-9 | Retinogram Abnormal, Visual Acuity Reduced
Patient was taking Cefuroxime (View Usage). After Cefuroxime was administered, patient had the following side effects: retinogram abnormal, visual acuity reduced on Aug 05, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 79 years of age, was diagnosed with cataract operation, mydriasis, cycloplegia and. Cefuroxime dosage: . During the same period patient was treated with ADRENALINE (View Adrenaline Review and Adrenaline Label ), SODIUM HYALURONATE (View Sodium Hyaluronate Review and Sodium Hyaluronate Label ), PHENYLEPHRINE (View Phenylephrine Review and Phenylephrine Label ), CYCLOPENTOLATE HCL (View Cyclopentolate Hcl Review and Cyclopentolate Hcl Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), LIGNOCAINE (View Lignocaine Review and Lignocaine Label ), HYALASE (View Hyalase Review and Hyalase Label ).

6305527-3 | Flushing, Infusion Site Inflammation, Infusion Site Pain, Rash, Tachycardia, Tachypnoea
Adverse event was reported on Jul 30, 2009 by a Male patient taking Cefuroxime (View Usage) (Dosage: 750 Mg, Intravenous) was diagnosed with postoperative care and. Location: UNITED KINGDOM , 16 years of age, Patient experienced the following unwanted or unexpected effects: flushing, infusion site inflammation, infusion site pain, rash (What is rash?), tachycardia, tachypnoea. During the same period patient was treated with METRONIDAZOLE (500 Mg, Intravenous) (View Metronidazole Review and Metronidazole Label ).

6303872-9 | Cardio-respiratory Arrest, Hypersensitivity
on Aug 07, 2009 Male patient from UNITED STATES , weighting 192.0 lb, was diagnosed with infection (What is infection?) and was treated with Cefuroxime (View Usage). Patient had the following side effects: cardio-respiratory arrest, hypersensitivity. Cefuroxime dosage: 500mg Bid Oral. Patient was hospitalized.

6301525-4 | Flushing, Infusion Site Inflammation, Infusion Site Pain, Rash, Tachycardia, Tachypnoea
on Jul 30, 2009 Male patient from UNITED KINGDOM , 16 years of age, was diagnosed with postoperative care and was treated with Cefuroxime (View Usage). After Cefuroxime was administered, patient had the following side effects: flushing, infusion site inflammation, infusion site pain, rash (What is rash?), tachycardia, tachypnoea. Cefuroxime dosage: . During the same period patient was treated with METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ).

6244159-2 | Blister
Patient was taking Cefuroxime (View Usage). Patient experienced the following unwanted or unexpected effects: blister on Jun 11, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 78 years of age, weighting 154.3 lb, was diagnosed with prophylaxis, hypertension, nausea (What is nausea?), pain (What is pain?) and. Cefuroxime dosage: 750 Mg, Unk. During the same period patient was treated with METRONIDAZOLE (505 Mg, Unk) (View Metronidazole Review and Metronidazole Label ), OXYCONTIN (10 Mg, Bid) (View Oxycontin Review and Oxycontin Label ), ATRACURIUM (Unk) (View Atracurium Review and Atracurium Label ), BENDROFLUMETHIAZIDE (2.5 Mg, Unk) (View Bendroflumethiazide Review and Bendroflumethiazide Label ), CYCLIZINE (50 Mg, Unk) (View Cyclizine Review and Cyclizine Label ), FRAGMIN (2500 Iu, Unk) (View Fragmin Review and Fragmin Label ), MIDAZOLAM HCL (Unk) (View Midazolam Hcl Review and Midazolam Hcl Label ), PARACETAMOL (1 G, Qid) (View Paracetamol Review and Paracetamol Label ).

6243193-6 | Abdominal Pain, Abdominal Pain Upper, Diarrhoea, Lacrimation Increased, Nausea, Nonspecific Reaction, Rhinorrhoea, Salivary Hypersecretion
Adverse event was reported on Jun 22, 2009 by a Female patient taking Cefuroxime (View Usage) (Dosage: 1 Tablet Twice Daily Po) was diagnosed with rash (What is rash?) and. Location: UNITED STATES , 52 years of age, weighting 178.0 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), abdominal pain upper, diarrhoea, lacrimation increased, nausea (What is nausea?), nonspecific reaction, rhinorrhoea, salivary hypersecretion.

6232930-2 | Pruritus, Rash Maculo-papular
on Jun 12, 2009 Male patient from UNITED STATES , 85 years of age, weighting 235.0 lb, was diagnosed with staphylococcal bacteraemia and was treated with Cefuroxime (View Usage). After Cefuroxime was administered, patient had the following side effects: pruritus, rash maculo-papular. Cefuroxime dosage: 500mg Every 12 Hours Po. During the same period patient was treated with VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), DOCUSATE (View Docusate Review and Docusate Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ).

6223578-4 | Clostridial Infection, Intestinal Ischaemia, Peritonitis, Refusal Of Treatment By Patient
on Jun 02, 2009 Female patient from , 87 years of age, was treated with Cefuroxime (View Usage). Patient experienced the following unwanted or unexpected effects: clostridial infection, intestinal ischaemia, peritonitis, refusal of treatment by patient. Cefuroxime dosage: 750mg, Tid, Iv. During the same period patient was treated with CIPROFLOXACIN (500mg, Bid, Oral) (View Ciprofloxacin Review and Ciprofloxacin Label ), LANSOPRAZOLE (30 Mg Bid Oral) (View Lansoprazole Review and Lansoprazole Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), CO AMILOFRUSE (View Co-amilofruse Review and Co-amilofruse Label ), ACETAMINOPHEN W/ CODEINE (View Acetaminophen W/ Codeine Review and Acetaminophen W/ Codeine Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ). Patient was hospitalized.

6211753-4 | Corneal Abrasion, Post Procedural Complication
Patient was taking Cefuroxime (View Usage). Patient had the following side effects: corneal abrasion, post procedural complication on May 18, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 59 years of age, was diagnosed with cataract operation, mydriasis, cycloplegia and. Cefuroxime dosage: 125 Mg, Intraocular Inj. During the same period patient was treated with DICLOFENAC SODIUM (Ophthalmic) (View Diclofenac Sodium Review and Diclofenac Sodium Label ), EPINEPHRINE (Intracameral) (View Epinephrine Review and Epinephrine Label ), HEALON (HYALURONATE SODIUM) (Intraocular Inj) (View Healon (hyaluronate Sodium) Review and Healon (hyaluronate Sodium) Label ), MINIMS PHENYLEPHRINE (PHENYLEPHRINE HYDROCHLORIDE) 10% (Opthalmic) (View Minims Phenylephrine (phenylephrine Hydrochloride) 10% Review and Minims Phenylephrine (phenylephrine Hydrochloride) 10% Label ), MINIMS (CYCLOPENTOLAT HYDROCHLORID (CYCLOPENTOLATE HYDROCHLORIDE) 1% (Opthalmic) (View Minims (cyclopentolat Hydrochlorid (cyclopentolate Hydrochloride) 1% Review and Minims (cyclopentolat Hydrochlorid (cyclopentolate Hydrochloride) 1% Label ), CO DYDRAMOL (DIHYDROCODEINE BITARTRATE, PARACETAMOL) (View Co-dydramol (dihydrocodeine Bitartrate, Paracetamol) Review and Co-dydramol (dihydrocodeine Bitartrate, Paracetamol) Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), MAXITROL (DEXAMETHASONE, NEOMYCIN SULFATE, POLYMYXIN B SULFATE) (View Maxitrol (dexamethasone, Neomycin Sulfate, Polymyxin B Sulfate) Review and Maxitrol (dexamethasone, Neomycin Sulfate, Polymyxin B Sulfate) Label ).

6203022-3 | Granulocytopenia, Toxic Epidermal Necrolysis
Adverse event was reported on May 13, 2009 by a Female patient taking Cefuroxime (View Usage) (Dosage: 500 Mg, Bid) was diagnosed with urinary tract infection (What is urinary tract infection?), renal failure chronic, hypertension and. Location: CROATIA (local name: Hrvatska) , 73 years of age, After Cefuroxime was administered, patient had the following side effects: granulocytopenia, toxic epidermal necrolysis. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ).

6181668-9 | Hypoaesthesia, Neuropathy Peripheral
on Apr 23, 2009 Female patient from GERMANY , 73 years of age, was diagnosed with breast infection and was treated with Cefuroxime (View Usage). Patient experienced the following unwanted or unexpected effects: hypoaesthesia, neuropathy peripheral. Cefuroxime dosage: 500mg Twice Per Day.

6178274-9 | Anaphylactic Shock, Oedema, Proteinuria, Urticaria
on Apr 21, 2009 Female patient from KENYA , weighting 149.9 lb, was treated with Cefuroxime (View Usage). Patient had the following side effects: anaphylactic shock, oedema, proteinuria, urticaria. Cefuroxime dosage: 500mg Per Day.

6171330-0 | Depression, Impaired Work Ability, Somnolence
Patient was taking Cefuroxime (View Usage). After Cefuroxime was administered, patient had the following side effects: depression (What is depression?), impaired work ability, somnolence on Apr 28, 2009 from UNITED STATES Additional patient health information: Female patient , 60 years of age, weighting 165.0 lb, was diagnosed with sinusitis (What is sinusitis?) and. Cefuroxime dosage: 250 Mg Twice Daily Po.

6170083-X | Erythema, Laryngeal Oedema
Adverse event was reported on Apr 23, 2009 by a Female patient taking Cefuroxime (View Usage) (Dosage: 500mg Single Dose) was diagnosed with sinusitis (What is sinusitis?) and. Location: BRAZIL , weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: erythema, laryngeal oedema. Patient was hospitalized.

6166907-2 | Anaphylactic Reaction, Neutrophil Count Increased, White Blood Cell Count Increased
on Apr 24, 2009 Male patient from UNITED KINGDOM , 88 years of age, was diagnosed with infection (What is infection?) and was treated with Cefuroxime (View Usage). Patient had the following side effects: anaphylactic reaction, neutrophil count increased, white blood cell count increased. Cefuroxime dosage: . During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), BETAHISTINE DIHYDROCHLORIDE (View Betahistine Dihydrochloride Review and Betahistine Dihydrochloride Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6152085-2 | Acute Coronary Syndrome, Arteriosclerosis Coronary Artery
on Mar 24, 2009 Male patient from TURKEY , 90 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Cefuroxime (View Usage). After Cefuroxime was administered, patient had the following side effects: acute coronary syndrome, arteriosclerosis coronary artery. Cefuroxime dosage: 750 Mg, Once + Im. Patient was hospitalized.

6151774-3 | Abdominal Pain, Erythema, Formication, Hypersensitivity, Hypoaesthesia, Hypoaesthesia Oral, Nausea
Patient was taking Cefuroxime (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), erythema, formication, hypersensitivity, hypoaesthesia, hypoaesthesia oral, nausea (What is nausea?) on Mar 31, 2009 from TURKEY Additional patient health information: Female patient , weighting 154.3 lb, was diagnosed with sinusitis (What is sinusitis?), pregnancy (What is pregnancy?) and. Cefuroxime dosage: . During the same period patient was treated with FERRO GLYCINE SULPHATE (View Ferro Glycine Sulphate Review and Ferro Glycine Sulphate Label ). Patient was hospitalized.

6146315-0 | Acute Coronary Syndrome, Arteriosclerosis Coronary Artery, Blood Creatine Phosphokinase Mb Increased, Electrocardiogram St Segment Elevation, Leukocytosis, Rash Pruritic, Troponin I Increased, Tryptase Increased, Type I Hypersensitivity
Adverse event was reported on Mar 22, 2009 by a Male patient taking Cefuroxime (View Usage) (Dosage: ) . Location: UNITED STATES , 90 years of age, Patient had the following side effects: acute coronary syndrome, arteriosclerosis coronary artery, blood creatine phosphokinase mb increased, electrocardiogram st segment elevation, leukocytosis, rash pruritic, troponin i increased, tryptase increased, type i hypersensitivity. Patient was hospitalized.

6140097-4 | Abdominal Pain Lower, Amenorrhoea, Iud Migration, Nausea, Staphylococcal Sepsis, Suprapubic Pain, Urinary Tract Infection
on Feb 24, 2009 Female patient from UNITED KINGDOM , 34 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), contraception and was treated with Cefuroxime (View Usage). After Cefuroxime was administered, patient had the following side effects: abdominal pain lower, amenorrhoea, iud migration, nausea (What is nausea?), staphylococcal sepsis, suprapubic pain, urinary tract infection (What is urinary tract infection?). Cefuroxime dosage: . During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), LEVONORGESTREL (20 Ug; Intrauterine) (View Levonorgestrel Review and Levonorgestrel Label ). Patient was hospitalized.

6134324-7 | Granulocytopenia, Toxic Epidermal Necrolysis
on Mar 13, 2009 Female patient from CROATIA (local name: Hrvatska) , 73 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), renal failure chronic, hypertension and was treated with Cefuroxime (View Usage). Patient experienced the following unwanted or unexpected effects: granulocytopenia, toxic epidermal necrolysis. Cefuroxime dosage: Unk. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ).

6127249-4 | Abdominal Pain Lower, Amenorrhoea, Iud Migration, Nausea, Staphylococcal Sepsis, Suprapubic Pain, Urinary Tract Infection
Patient was taking Cefuroxime (View Usage). Patient had the following side effects: abdominal pain lower, amenorrhoea, iud migration, nausea (What is nausea?), staphylococcal sepsis, suprapubic pain, urinary tract infection (What is urinary tract infection?) on Mar 13, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 34 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), contraception and. Cefuroxime dosage: . During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), LEVONORGESTREL (20 Ug; ;intrauterine) (View Levonorgestrel Review and Levonorgestrel Label ). Patient was hospitalized.